Two MIT seniors and alumnus Noam Angrist have been named Rhodes Scholars, reports Dave Collins for the Associated Press. “It’s a total dream come true,” says Angrist. “The skills I will get at (Oxford) are just incredible, and I’ll come back into the world fully equipped to do what I love to do.”
Philip Ball of The Guardian speaks with graduate student Steve Ramirez about the potential for neuroscientist to one day be able to replace bad memories with good ones. “I see a world where we can reactivate any kind of memory we like, or erase unwanted memories,” says Ramirez.
Richard Knox writes for WBUR about Grace Silva, a cancer patient whose tumor was analyzed by a team from MIT and Harvard. The team uncovered genetic mutations in her tumor that allowed them to treat her with a drug matched precisely to her condition, a model for how cancer researchers hope to eventually treat all patients.
Niina Heikkinen reports for Scientific American that MIT researchers have identified a new way to make yeast more ethanol-tolerant. The researchers were able to improve “alcohol tolerance and extend the amount of time that individual cells could produce ethanol.”
Thomas Burton of The Wall Street Journal writes that MIT researchers were among those awarded the first research grants under President Obama’s new BRAIN Initiative. Burton writes that one of the MIT grants will go toward “determining which exact brain circuits are involved in generating short-term memories that influence decisions.”
MIT neuroscientists were among the recipients of new grants for brain research from the National Institutes of Health, reports Jon Hamilton for NPR. Hamilton explains that as part of one grant, “Researchers from the Massachusetts Institute of Technology will try to adapt functional MRI so that it can show the activity of individual brain cells.”
The Boston Globe writes about Professor Sangeeta Bhatia's commitment to mentoring her students. “It's heartening to know that, tucked away in labs all over our region, solution-driven scientists like Sangeeta Bhatia are tinkering and building — and encouraging others to do the same.”
New research by Professor Ann Graybiel may indicate that the FOXP2 gene in humans plays a major role in how we learn speech, writes Chris Higgins for Wired. Mice given the gene were able to learn their way through a maze more quickly than those without it.
Jacqueline Howard of The Huffington Post writes about research by Professor Ann Graybiel that looked at the effect of the human Foxp2 gene in mice. The work could lead to a greater understanding of how the human brain learns speech.
Sharon Begley of Reuters writes about Professor Ann Graybiel’s research on the effect of the human FOXP2 gene on mice. “By isolating the effects of one gene, the work sheds light on its function and hints at the evolutionary changes that led to the unique capabilities of the human brain,” writes Begley.
Research by Professor Ann Graybiel demonstrated that providing mice with the human version of the FOXP2 gene allowed them to learn repetitive patterns more quickly, reports Clare Wilson of The New Scientist. This may demonstrate that the gene plays an important role in how humans learn to speak, says Graybiel.
In an article for USA Today, Megan Cahill highlights MIT’s top-ranked biology program. “As a top research university with small class sizes, MIT offers a program that allows students to work closely with professors and their peers on various research projects,” she writes.
Kat McGowan of The Scientific American cites research by Professor Angelica Amon that indicates recent findings may overestimate the amount of genetic variation in healthy human bodies. “Having the wrong chromosome number is not a good thing,” says Amon.
Boston Globe reporter Chris Reify writes that Professor Sangeeta Bhatia has been awarded the 2014 $500,000 Lemelson-MIT Prize. “Dr. Bhatia is a wonderful example of a woman who has used her brilliance, skill and creativity to radically improve the detection and treatment of serious global health issues,” says Dorothy Lemelson, Lemelson Foundation chair.
NBC News reports that MIT Prof. Sangeeta Bhatia has been awarded the Lemelson-MIT prize for her work designing miniaturized biomedical tools. "As innovations emerge, we're constantly asking whether they can be repurposed for one of the two diseases we concentrate on: liver disease and cancer,” says Bhatia.